Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma

Modern Pathology

Volumn 9, Issue 9, 1996, Pages 925-929

  Kumar, S ^a   Green, G A ^a   Teruya Feldstein, J ^a   Raffeld, M ^a   Jaffe, E S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CD23; Mantle cell lymphoma; Paraffin section immunostaining; Small lymphocytic lymphoma

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; LEUKOSIALIN;

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; LYMPHOMA, SMALL LYMPHOCYTIC; PARAFFIN EMBEDDING; RECEPTORS, IGE; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 0029759605     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ben-Ezra J, Burke JS, Swartz WG, et al.: Small lymphocytic lymphoma: A clinicopathologic analysis of 268 cases. Blood 73:579, 1989
2. Perry DA, Bast MA, Armitage JO, Weisenburger DD: Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Cancer 66:1995, 1990
3. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES. Lymphocytic llymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14:752, 1990
4. Rozman C, Montserrat E: Chronic lymphocytic leukemia. N Engl J Med 333:1052, 1995
5. Zuckerberg LR, Medeiros LJ, Ferry JA, Harris NL: Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 100:373, 1993
6. Dorfman DM, Pinkus GS: Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol 7:326, 1994
7. Stein H, Lennert K, Feller AC, Mason DY. Immunohistochemical analysis of human lymphoma: Correlation of histological and immunological categories. Adv Cancer Res 42: 67, 1984
8. Harris NL, Jaffe ES, Stein H, et al.: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84: 1361, 1994
9. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112, 1982
10. Pallesen G: The distribution of CD23 in normal human tissues and in malignant lymphomas. In Leukocyte Typing III, edited by McMichael AJ, p 383. New York, Oxford University Press, 1987
11. Orazi A, Catoretti G, Polli N, Delia D, Rilke F: Distinct morphophenotypic features of chronic B-cell leukemias identified with CD1c and CD23 antibodies. Eur J Haematol 47:28, 1991
12. Rowlands DC, Hansel TT, Crocker J: Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections. J Pathol 160:239, 1990
13. Murray PG, Janmohammed RMI, Crocker J: CD23 expression in non-Hodgkin lymphoma: Immunohistochemical demonstration using the antibody BU38 on paraffin sections. J Pathol 165:125, 1991
14. Salter DM, Krajewski AS, Cunningham S: Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma. J Pathol 154:209, 1988
15. Medeiros LJ, Van Krieken JH, Jaffe ES, Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 76:2086, 1990
16. Kumar S, Krenacs L, Otsuki T, Kumar D, Harris CA, Wellman A, Jaffe ES, Raffeld M. Bcl-1 rearrangement and Cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol (in press)